Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Prevalence and Attributable Health Burden of Chronic Respiratory Diseases, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 Publisher Pubmed



Soriano JB1, 2, 3 ; Kendrick PJ4 ; Paulson KR4 ; Gupta V4 ; Abrams EM10, 12 ; Adedoyin RA14 ; Adhikari TB15, 16 ; Advani SM17, 18 ; Agrawal A19, 20 ; Ahmadian E21, 23 ; Alahdab F24 ; Aljunid SM25, 26 ; Altirkawi KA27 ; Alvisguzman N29, 30 Show All Authors
Authors
  1. Soriano JB1, 2, 3
  2. Kendrick PJ4
  3. Paulson KR4
  4. Gupta V4
  5. Abrams EM10, 12
  6. Adedoyin RA14
  7. Adhikari TB15, 16
  8. Advani SM17, 18
  9. Agrawal A19, 20
  10. Ahmadian E21, 23
  11. Alahdab F24
  12. Aljunid SM25, 26
  13. Altirkawi KA27
  14. Alvisguzman N29, 30
  15. Anber NH31
  16. Andrei CL32
  17. Anjomshoa M35
  18. Ansari F22, 36
  19. Anto JM37, 38
  20. Arabloo J39
  21. Athari SM42, 46
  22. Athari SS46
  23. Awoke N47
  24. Badawi A48, 49
  25. Banoub JAM51, 52
  26. Bennett DA53
  27. Bensenor IM54
  28. Berfield KSS5, 55
  29. Bernstein RS56
  30. Bhattacharyya K57, 58
  31. Bijani A59
  32. Brauer M4, 13
  33. Bukhman G61, 64
  34. Butt ZA65, 66
  35. Camera LA67, 68
  36. Car J70, 72
  37. Carrero JJ74
  38. Carvalho F75
  39. Castanedaorjuela CA77, 78
  40. Choi JYJ79
  41. Christopher DJ80
  42. Cohen AJ4, 81
  43. Dandona L6, 82, 83
  44. Dandona R4, 82
  45. Dang AK84
  46. Daryani A85
  47. De Courten B88
  48. Demeke FM91
  49. Demoz GT92
  50. De Neve JW94
  51. Desai R96
  52. Dharmaratne SD4, 6, 97
  53. Diaz D98, 99
  54. Douiri A100
  55. Driscoll TR102
  56. Duken EE105, 107
  57. Eftekhari A43, 108
  58. Elkout H109, 110
  59. Endries AY111
  60. Fadhil I112
  61. Faro A113
  62. Farzadfar F114
  63. Fernandes E76
  64. Filip I123, 124
  65. Fischer F125
  66. Foroutan M126
  67. Garciagordillo MA127
  68. Gebre AK128, 135
  69. Gebremedhin KB136
  70. Gebremeskel GG93, 129
  71. Gezae KE130
  72. Ghoshal AG140, 141
  73. Gill PS142
  74. Gillum RF143, 144
  75. Goudarzi H145, 146
  76. Guo Y89, 147
  77. Gupta R148, 149
  78. Hailu GB131
  79. Hasanzadeh A44, 115
  80. Hassen HY150, 151
  81. Hay SI4, 6
  82. Hoang CL152
  83. Hole MK153
  84. Horita N154, 155
  85. Hosgood HD156
  86. Hostiuc M33
  87. Househ M157
  88. Ilesanmi OS158, 160
  89. Ilic MD161
  90. Irvani SSN163
  91. Islam SMS103, 166
  92. Jakovljevic M162, 167
  93. Jamal AA28
  94. Jha RP168, 169
  95. Jonas JB170, 171
  96. Kabir Z172
  97. Kasaeian A40, 116
  98. Kasahun GG92
  99. Kassa GM173
  100. Kefale AT174, 175
  101. Kengne AP176, 178
  102. Khader YS180
  103. Khafaie MA181
  104. Khan EA183
  105. Khan J184
  106. Khubchandani J185
  107. Kim YE186, 187
  108. Kim YJ188
  109. Kisa S188
  110. Kisa A189, 190
  111. Knibbs LD191
  112. Komaki H192, 193
  113. Koul PA194
  114. Koyanagi A195, 196
  115. Kumar GA82
  116. Lan Q197
  117. Lasrado S198
  118. Lauriola P199
  119. La Vecchia C200
  120. Le TT201
  121. Leigh J104
  122. Levi M203, 204
  123. Li S90
  124. Lopez AD4, 6, 205
  125. Lotufo PA206
  126. Madotto F207
  127. Mahotra NB208
  128. Majdan M209
  129. Majeed A72
  130. Malekzadeh R117, 210
  131. Mamun AA211
  132. Manafi N11, 41
  133. Manafi F50
  134. Mantovani LG207, 212
  135. Meharie BG213
  136. Meles HG134
  137. Meles GG132
  138. Menezes RG216
  139. Mestrovic T217, 218
  140. Miller TR219, 220
  141. Mini GK221, 222
  142. Mirrakhimov EM223, 224
  143. Moazen B94, 225
  144. Mohammad KA226
  145. Mohammed S94, 227
  146. Mohebi F114, 118
  147. Mokdad AH4, 6
  148. Molokhia M101
  149. Monasta L228
  150. Moradi M229
  151. Moradi G233, 234
  152. Morawska L235
  153. Mousavi SM119
  154. Musa KI236
  155. Mustafa G237, 238
  156. Naderi M230
  157. Naghavi M4, 6
  158. Naik G239
  159. Nair S241, 242
  160. Nangia V243
  161. Nansseu JR244, 245
  162. Nazari J246
  163. Ndwandwe DE247
  164. Negoi RI34, 248
  165. Nguyen TH152
  166. Nguyen CT84
  167. Nguyen HLT84
  168. Nixon MR4
  169. Oforiasenso R89, 249
  170. Ogbo FA250
  171. Olagunju AT251, 253
  172. Olagunju TO252
  173. Oren E9, 254
  174. Ortiz JR7, 202
  175. Owolabi MO159, 255
  176. Mahesh M159, 256
  177. Pakhale S257
  178. Pana A258, 259
  179. Pandajonas S95
  180. Park EK260
  181. Pham HQ84
  182. Postma MJ261, 262
  183. Pourjafar H45, 263
  184. Poustchi H117
  185. Radfar A264
  186. Rafiei A86, 87
  187. Rahim F120, 182
  188. Rahman MHU265, 266, 267
  189. Rahman MA72
  190. Rawaf S72, 268
  191. Rawaf DL73, 269
  192. Rawal L270
  193. Reitsma MB4
  194. Roever L271
  195. Ronfani L228
  196. Roro EM106, 137
  197. Roshandel G272
  198. Rudd KE273
  199. Sabde YD274
  200. Sabour S164
  201. Saddik B275
  202. Safari S165
  203. Saleem K276, 277
  204. Samy AM278
  205. Santricmilicevic MM279, 280
  206. Sao Jose BP281
  207. Sartorius B6, 282
  208. Satpathy M283, 284
  209. Savic M285
  210. Sawhney M286
  211. Sepanlou SG117, 210
  212. Shaikh MA287
  213. Sheikh A62, 288
  214. Shigematsu M289
  215. Shirkoohi R121, 122
  216. Si S90
  217. Siabani S231, 290
  218. Singh V291
  219. Singh JA240, 292
  220. Soljak M71, 72
  221. Somayaji R8, 293
  222. Soofi M232
  223. Soyiri IN294
  224. Tefera YM214, 295
  225. Temsah MH27
  226. Tesfay BE296
  227. Thakur JS297
  228. Toma AT298
  229. Tortajadagirbes M299, 300
  230. Tran KB301, 302
  231. Tran BX303
  232. Tudor Car L71
  233. Ullah I304
  234. Vacante M305
  235. Valdez PR69, 306
  236. Van Boven JFM261
  237. Vasankari TJ307
  238. Veisani Y308
  239. Violante FS309, 310
  240. Wagner GR63
  241. Westerman R311
  242. Wolfe CDA100, 312
  243. Wondafrash DZ133, 138
  244. Wondmieneh AB139, 215
  245. Yonemoto N313, 314
  246. Yoon SJ186
  247. Zaidi Z315
  248. Zamani M60
  249. Zar HJ177, 179
  250. Zhang Y316, 317
  251. Vos T4, 6

Source: The Lancet Respiratory Medicine Published:2020


Abstract

Background: Previous attempts to characterise the burden of chronic respiratory diseases have focused only on specific disease conditions, such as chronic obstructive pulmonary disease (COPD) or asthma. In this study, we aimed to characterise the burden of chronic respiratory diseases globally, providing a comprehensive and up-to-date analysis on geographical and time trends from 1990 to 2017. Methods: Using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017, we estimated the prevalence, morbidity, and mortality attributable to chronic respiratory diseases through an analysis of deaths, disability-adjusted life-years (DALYs), and years of life lost (YLL) by GBD super-region, from 1990 to 2017, stratified by age and sex. Specific diseases analysed included asthma, COPD, interstitial lung disease and pulmonary sarcoidosis, pneumoconiosis, and other chronic respiratory diseases. We also assessed the contribution of risk factors (smoking, second-hand smoke, ambient particulate matter and ozone pollution, household air pollution from solid fuels, and occupational risks) to chronic respiratory disease-attributable DALYs. Findings: In 2017, 544·9 million people (95% uncertainty interval [UI] 506·9–584·8) worldwide had a chronic respiratory disease, representing an increase of 39·8% compared with 1990. Chronic respiratory disease prevalence showed wide variability across GBD super-regions, with the highest prevalence among both males and females in high-income regions, and the lowest prevalence in sub-Saharan Africa and south Asia. The age-sex-specific prevalence of each chronic respiratory disease in 2017 was also highly variable geographically. Chronic respiratory diseases were the third leading cause of death in 2017 (7·0% [95% UI 6·8–7·2] of all deaths), behind cardiovascular diseases and neoplasms. Deaths due to chronic respiratory diseases numbered 3 914 196 (95% UI 3 790 578–4 044 819) in 2017, an increase of 18·0% since 1990, while total DALYs increased by 13·3%. However, when accounting for ageing and population growth, declines were observed in age-standardised prevalence (14·3% decrease), age-standardised death rates (42·6%), and age-standardised DALY rates (38·2%). In males and females, most chronic respiratory disease-attributable deaths and DALYs were due to COPD. In regional analyses, mortality rates from chronic respiratory diseases were greatest in south Asia and lowest in sub-Saharan Africa, also across both sexes. Notably, although absolute prevalence was lower in south Asia than in most other super-regions, YLLs due to chronic respiratory diseases across the subcontinent were the highest in the world. Death rates due to interstitial lung disease and pulmonary sarcoidosis were greater than those due to pneumoconiosis in all super-regions. Smoking was the leading risk factor for chronic respiratory disease-related disability across all regions for men. Among women, household air pollution from solid fuels was the predominant risk factor for chronic respiratory diseases in south Asia and sub-Saharan Africa, while ambient particulate matter represented the leading risk factor in southeast Asia, east Asia, and Oceania, and in the Middle East and north Africa super-region. Interpretation: Our study shows that chronic respiratory diseases remain a leading cause of death and disability worldwide, with growth in absolute numbers but sharp declines in several age-standardised estimators since 1990. Premature mortality from chronic respiratory diseases seems to be highest in regions with less-resourced health systems on a per-capita basis. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
Other Related Docs